Idex Corp (IEX) financial statements: income statement, balance sheet and cash flow
Idex Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Idex Corp reported revenue of $3.5B (+5.8% year on year) and net income of $483.2M (-4.3% year on year).
Income statement
Idex Corp income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$3.5B
$3.3B
$3.3B
$3.2B
Cost of sales
$1.9B
$1.8B
$1.8B
$1.8B
Gross profit
$1.5B
$1.4B
$1.4B
$1.4B
Selling, general and administrative expenses
$818.8M
$758.7M
$703.5M
$652.7M
Restructuring expenses and asset impairments
$20.7M
$9.3M
$10.9M
$22.8M
Operating income
$699.3M
$677.2M
$732.5M
$751.4M
Gain on sale of businesses – net
$0
($4.0M)
($84.7M)
($34.8M)
Other expense (income) – net
$2.3M
($2.6M)
$5.2M
($3.9M)
Interest expense - net
$64.4M
$44.5M
—
—
Income before income taxes
$632.6M
$639.3M
$760.3M
$749.4M
Provision for income taxes
$150.1M
$134.7M
$164.7M
$162.7M
Net income
$482.5M
$504.6M
$595.6M
$586.7M
Net loss attributable to noncontrolling interest
$700.0K
$400.0K
$500.0K
$200.0K
Net income attributable to IDEX
$483.2M
$505.0M
$596.1M
$586.9M
Basic earnings per common share attributable to IDEX (in dollar per share)
$6.41
$6.66
$7.87
$7.74
Diluted earnings per common share attributable to IDEX (in dollar per share)
$6.41
$6.64
$7.85
$7.71
Basic weighted average common shares outstanding (in shares)
75.3M
75.7M
75.6M
75.7M
Diluted weighted average common shares outstanding (in shares)
75.3M
75.9M
75.9M
76.0M
Idex Corp income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Net sales
$920.6M
$886.9M
$878.7M
$865.4M
Cost of sales
$493.8M
$488.8M
$488.1M
$473.2M
Gross profit
$426.8M
$398.1M
$390.6M
$392.2M
Selling, general and administrative expenses
$224.1M
$218.3M
$204.7M
$203.6M
Restructuring expenses and asset impairments
$2.8M
$7.4M
$100.0K
$700.0K
Operating income
$199.9M
$172.4M
$185.8M
$187.9M
Other (income) expense – net
($1.3M)
($600.0K)
($1.2M)
$2.4M
Interest expense – net
$15.1M
$16.0M
$16.5M
$15.6M
Income before income taxes
$186.1M
$157.0M
$170.5M
$169.9M
Provision for income taxes
$42.7M
$37.1M
$42.8M
$38.8M
Net income
$143.4M
$119.9M
$127.7M
$131.1M
Net loss attributable to noncontrolling interest
$0
$100.0K
$100.0K
$500.0K
Net income attributable to IDEX
$143.4M
$120.0M
$127.8M
$131.6M
Basic earnings per common share attributable to IDEX (in dollars per share)
$1.94
$1.61
$1.70
$1.74
Diluted earnings per common share attributable to IDEX (in dollars per share)
$1.93
$1.61
$1.70
$1.74
Basic weighted average common shares outstanding (in shares)
74.0M
74.3M
75.1M
75.5M
Diluted weighted average common shares outstanding (in shares)
74.2M
74.4M
75.2M
75.5M
Balance sheet
Idex Corp balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$580.0M
$620.8M
$534.3M
$430.2M
Receivables – net
$521.7M
$465.9M
$427.8M
$442.8M
Inventories – net
$479.4M
$429.7M
$420.8M
$470.9M
Other current assets
$62.1M
$76.3M
$63.4M
$55.4M
Total current assets
$1.6B
$1.6B
$1.4B
$1.4B
Property, plant and equipment – net
$468.0M
$460.4M
$430.3M
$382.1M
Goodwill
$3.4B
$3.3B
$2.8B
$2.6B
Intangible assets – net
$1.2B
$1.3B
$1.0B
$947.8M
Other noncurrent assets
$153.9M
$155.7M
$138.5M
$144.6M
Total assets
$6.9B
$6.7B
$5.9B
$5.5B
Trade accounts payable
$224.7M
$197.8M
$179.7M
$208.9M
Accrued expenses
$297.0M
$278.7M
$271.5M
$289.1M
Current portion of long-term borrowings
$700.0K
$100.7M
$600.0K
—
Dividends payable
$53.0M
$52.5M
$48.5M
$45.6M
Total current liabilities
$575.4M
$629.7M
$500.3M
$543.6M
Long-term borrowings – net
$1.8B
$1.9B
$1.3B
$1.5B
Deferred income taxes
$303.0M
$267.2M
$291.9M
$264.2M
Other noncurrent liabilities
$202.3M
$194.8M
$206.7M
$195.8M
Total liabilities
$2.9B
$3.0B
$2.3B
$2.5B
Authorized: 5.0 million shares, $0.01 per share par value; Issued: None
$0.00
$0.00
$0.00
$0.00
Authorized: 150.0 million shares, $0.01 per share par value Issued: 90.1 million shares at both December 31, 2025 and 2024
$900000.00
$900000.00
$900000.00
$900000.00
Treasury stock at cost: 15.5 million shares at December 31, 2025 and 14.2 million shares at December 31, 2024
-1.4B
-1.2B
-1.2B
—
Additional paid-in capital
$892.1M
$864.8M
$839.0M
$817.2M
Retained earnings
$4.5B
$4.2B
$3.9B
$3.5B
Accumulated other comprehensive income (loss)
$57.6M
($130.9M)
($45.8M)
($126.2M)
Total shareholders’ equity
$4.0B
$3.8B
$3.5B
$3.0B
Noncontrolling interest
($1.3M)
($600.0K)
($200.0K)
$300.0K
Total equity
$4.0B
$3.8B
$3.5B
$3.0B
Total liabilities and equity
$6.9B
$6.7B
$5.9B
$5.5B
Idex Corp balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$621.3M
$586.2M
$593.8M
$568.2M
Receivables – net
$547.8M
$553.0M
$500.2M
$476.1M
Inventories – net
$520.3M
$501.0M
$495.1M
$487.8M
Other current assets
$83.9M
$76.5M
$65.8M
$84.4M
Total current assets
$1.8B
$1.7B
$1.7B
$1.6B
Property, plant and equipment – net of accumulated depreciation of $686.4 and $654.3 at June 30, 2026 and December 31, 2025, respectively
$463.6M
$462.3M
$468.6M
$464.8M
Goodwill
$3.4B
$3.4B
$3.4B
$3.4B
Intangible assets – net
$1.2B
$1.2B
$1.3B
$1.3B
Other noncurrent assets
$146.0M
$149.2M
$155.9M
$156.8M
Total assets
$6.9B
$6.9B
$7.0B
$6.9B
Trade accounts payable
$233.7M
$224.8M
$208.1M
$204.2M
Accrued expenses
$293.5M
$280.6M
$302.0M
$271.3M
Current portion of long-term borrowings
$400.0K
$500.0K
$700.0K
$800.0K
Dividends payable
$54.0M
$100.0K
$53.2M
$53.5M
Total current liabilities
$581.6M
$506.0M
$564.0M
$529.8M
Long-term borrowings – net
$1.9B
$1.9B
$1.9B
$1.8B
Deferred income taxes
$297.8M
$299.5M
$287.8M
$283.2M
Other noncurrent liabilities
$185.5M
$192.9M
$206.2M
$205.6M
Total liabilities
$2.9B
$2.9B
$3.0B
$2.9B
Authorized: 5.0 million shares, $0.01 per share par value; Issued: None
$0.00
$0.00
$0.00
$0.00
Authorized: 150.0 million shares, $.01 per share par value Issued: 90.1 million shares at both June 30, 2026 and December 31, 2025
$900000.00
$900000.00
$900000.00
$900000.00
Treasury stock at cost: 16.1 million shares at June 30, 2026 and 15.5 million shares at December 31, 2025
-1.5B
-1.5B
-1.3B
-1.3B
Additional paid-in capital
$875.2M
$868.5M
$888.5M
$883.6M
Retained earnings
$4.7B
$4.6B
$4.4B
$4.4B
Accumulated other comprehensive income
$1.6M
$13.9M
$45.3M
$48.2M
Total shareholders’ equity
$4.0B
$4.0B
$4.0B
$4.0B
Noncontrolling interest
($1.4M)
($1.4M)
($1.3M)
($1.2M)
Total equity
$4.0B
$4.0B
$4.0B
$4.0B
Total liabilities and equity
$6.9B
$6.9B
$7.0B
$6.9B
Cash flow statement
Idex Corp cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income
$482.5M
$504.6M
$595.6M
$586.7M
Gain on sale of businesses – net
$0
($4.0M)
($84.7M)
($34.8M)
Asset Impairments
$700.0K
$100.0K
$800.0K
$17.4M
Credit loss on note receivable from collaborative partner
$0
$0
$7.7M
—
Depreciation
$75.8M
$68.5M
$57.2M
$50.7M
Amortization of intangible assets
$130.7M
$107.1M
$94.9M
$69.0M
Share-based compensation expense
$27.3M
$25.8M
$21.8M
$21.6M
Deferred income taxes
$12.8M
($19.4M)
($14.7M)
($18.5M)
Receivables – net
($41.2M)
($16.9M)
$20.5M
($71.7M)
Inventories – net
($34.2M)
$17.6M
$66.2M
($72.4M)
Other current assets
$1.6M
($100.0K)
($6.5M)
($500.0K)
Trade accounts payable
$15.2M
$8.9M
($25.3M)
$17.6M
Deferred revenue
$2.7M
($17.9M)
$12.7M
($25.0M)
Accrued expenses
$1.8M
($8.6M)
($34.8M)
$16.6M
Other – net
$4.7M
$2.4M
$5.3M
$2.5M
Net cash flows provided by operating activities
$680.4M
$668.1M
$716.7M
$557.4M
Capital expenditures
($63.6M)
($65.1M)
($89.9M)
($68.0M)
Acquisition of businesses, net of cash acquired
($76.2M)
($984.5M)
($311.8M)
($945.6M)
Proceeds from sale of businesses, net of cash remitted
$0
$45.1M
$118.6M
$49.4M
Purchase of marketable securities
$0
$0
($29.0M)
$0
Proceeds from sale of marketable securities
$0
$4.5M
$24.8M
$39.7M
Other – net
$2.2M
($6.5M)
$3.5M
$1.4M
Net cash flows used in investing activities
($137.6M)
($1.0B)
($283.8M)
($917.2M)
Borrowings under revolving credit facilities
$252.0M
$279.3M
$0
$210.4M
Payments under revolving credit facilities
($322.9M)
($69.1M)
$0
($135.0M)
Proceeds from issuance of long-term borrowings
$0
$496.7M
$100.0M
$200.0M
Payment of long-term borrowings
($100.0M)
($50.0M)
($250.0M)
$0
Cash dividends paid to shareholders
($212.6M)
($205.3M)
($190.7M)
($177.4M)
(Payments) proceeds from share issuances, net of shares withheld for taxes
-500.0K
—
—
—
Repurchases of common stock
($247.8M)
$0
($24.2M)
($148.1M)
Other – net
($800.0K)
($700.0K)
($1.3M)
—
Net cash flows (used in) provided by financing activities
($632.6M)
$465.9M
($344.7M)
($37.8M)
Effect of exchange rate changes on cash and cash equivalents
$36.8M
($22.9M)
$15.9M
($27.6M)
Net (decrease) increase in cash and cash equivalents and restricted cash
($53.0M)
$104.6M
$104.1M
($425.2M)
Cash and cash equivalents and restricted cash at beginning of year
$638.9M
$534.3M
$430.2M
$855.4M
Cash and cash equivalents and restricted cash at end of year
$585.9M
$638.9M
—
—
Interest
$72.2M
$47.4M
$50.8M
$37.1M
Income taxes - net
$134.6M
$171.4M
$199.5M
$175.6M
Idex Corp cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income
$263.3M
$119.9M
$354.2M
$226.5M
Asset impairments
$4.8M
$4.8M
$700.0K
$600.0K
Depreciation
$40.1M
$19.9M
$56.5M
$37.4M
Amortization of intangible assets
$67.0M
$33.8M
$96.5M
$63.5M
Share-based compensation expense
$21.9M
$15.8M
$23.7M
$18.8M
Deferred income taxes
($1.3M)
($600.0K)
($1.0M)
$1.6M
Receivables – net
($30.7M)
($35.4M)
($20.2M)
$1.6M
Inventories – net
($45.7M)
($25.5M)
($49.4M)
($45.6M)
Other current assets
($21.4M)
($15.1M)
($1.4M)
($21.8M)
Trade accounts payable
$9.2M
$600.0K
($1.1M)
($700.0K)
Deferred revenue
$2.7M
$4.2M
($1.1M)
$6.4M
Accrued expenses
($8.0M)
($18.8M)
$10.4M
($22.4M)
Other – net
$1.8M
$100.0K
$3.1M
$1.5M
Net cash flows provided by operating activities
$303.7M
$103.7M
$470.9M
$267.4M
Capital expenditures
($40.7M)
($17.7M)
($43.9M)
($29.1M)
Acquisition of business, net of cash acquired
$0
$0
($76.5M)
$4.2M
Other – net
($2.0M)
($2.7M)
$400.0K
$400.0K
Net cash flows used in investing activities
($42.7M)
($20.4M)
($120.0M)
($24.5M)
Borrowings under revolving credit facilities
$205.0M
$100.0M
$197.0M
$50.0M
Payments under revolving credit facilities
($163.3M)
($45.3M)
($185.8M)
($92.7M)
Payment of long-term borrowings
$0
—
($100.0M)
($100.0M)
Cash dividends paid to shareholders
($106.7M)
($52.8M)
($159.4M)
($105.9M)
Proceeds (payments) from share issuances, net of shares withheld for taxes
10.6M
5.8M
-1.2M
-200.0K
Repurchases of common stock
($153.4M)
($76.3M)
($175.0M)
($100.0M)
Other – net
($300.0K)
($200.0K)
($500.0K)
($400.0K)
Net cash flows used in financing activities
($208.1M)
($68.8M)
($424.9M)
($349.2M)
Effect of exchange rate changes on cash and cash equivalents
($10.7M)
($8.6M)
$34.8M
$37.4M
Net increase (decrease) in cash and cash equivalents and restricted cash
$42.2M
$5.9M
($39.2M)
($68.9M)
Cash and cash equivalents and restricted cash at beginning of year
$585.9M
$585.9M
$638.9M
$638.9M
Cash and cash equivalents and restricted cash at end of period